Abstract
Mesenchymal stem cells (MSCs) are adult stem cells which are, due to their huge differentiation potential, potent immunomodulatory and pro-angiogenic properties, considered as new therapeutic agents in regenerative medicine. Although MSC-based therapy holds a great potential in the treatment of inflammatory and degenerative diseases, there are several issues that limit therapeutic efficacy of MSCs. Due to the low survival of engrafted cells, high number of MSCs has to be transplanted to achieve optimal therapeutic benefits. A large number of evidence demonstrated that modulation of autophagy-related pathways in engrafted MSCs may increase viability and survival of transplanted MSCs, enhancing their potential for differentiation. immunomodulatory and pro-angiogenic properties. In this chapter, we summarized current knowledge about the role of autophagy in MSC-based therapy of inflammatory, ischemic, and degenerative diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- 3-MA:
-
3-methyladenine
- aGVHD:
-
Acute Graft-versus-Host Disease
- AT-MSCs:
-
Adipose tissue-derived mesenchymal stem cells
- AD:
-
Alzheimer's disease
- ATG7:
-
Autophagy Related gene 7
- bFGF:
-
Basic fibroblast growth factor
- Bcl-2:
-
B-cell leukemia/lymphoma-2
- CNS:
-
Central nervous system
- CMA:
-
Chaperone-mediated autophagy
- DCs:
-
Dendritic cells
- EAE:
-
Experimental autoimmune encephalomyelitis
- iPSC-MSC-EVs:
-
Extracellular vesicles isolated from MSCs previously derived from human induced pluripotent stem cells
- GIOP:
-
Glucocorticoid-induced osteoporosis
- HLA:
-
Human leukocyte antigen
- HD:
-
Huntington disease
- IDO:
-
Indoleamine 2,3-dioxygenase
- IFN-γ:
-
Interferon gamma
- JAK-STAT:
-
Janus kinase-Signal transducer and activator of transcription
- JNK:
-
Jun N-terminal kinases
- mTORC1:
-
Mechanistic target of rapamycin complex 1
- MSCs:
-
Mesenchymal stem cells
- MAPKs:
-
Mitogen-activated protein kinases
- MAIT:
-
Mucosal-associated invariant T
- NF-κB:
-
Nuclear factor kappa-light-chain-enhancer of activated B cells
- PD:
-
Parkinson's disease
- PE:
-
phosphatidyl ethanol amine
- PI3K:
-
Phosphatidylinositol-3-kinase complex
- PGE2:
-
Prostaglandin E2
- PKB/AKT:
-
protein kinase B activation
- ROS:
-
reactive oxygen species
- SDF-1:
-
stromal cell derived factor 1
- SLE:
-
ystemic lupus erythematosus
- (T-MSCs):
-
Tonsil-derived MSCs
- (TGF-β):
-
transforming growth factor beta
- TNF-α:
-
Tumor necrosis factor alpha
- UVRAG:
-
UV irradiation resistance-associated tumor suppressor gene
- Vps34:
-
Vacuolar protein sorting 34
References
Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP (1968) Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6:230–47
Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393–403
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–7
Katz AJ, Tholpady A, Tholpady SS, Shang H, Ogle RC (2005) Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 23:412–423
Kassis I, Zangi L, Rivkin R, Levdansky L, Samuel S, Marx G, Gorodetsky R (2006) Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant 37:967–976
Agha-Hosseini F, Jahani MA, Jahani M, Mirzaii-Dizgah I, Ali-Moghaddam K (2010) In vitro isolation of stem cells derived from human dental pulp. Clin Transplant 24:E23–E28
Roubelakis MG, Pappa KI, Bitsika V, Zagoura D, Vlahou A, Papadaki HA, Antsaklis A, Anagnou NP (2007) Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev. 16:931–952
Vellasamy S, Sandrasaigaran P, Vidyadaran S, George E, Ramasamy R (2012) Isolation and characterisation of mesenchymal stem cells derived from human placenta tissue. World J Stem Cells 4:53–61
Girdlestone J, Limbani VA, Cutler AJ, Navarrete CV (2009) Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions. Cytotherapy 11:738–748
Batsali AK, Pontikoglou C, Koutroulakis D, Pavlaki KI, Damianaki A, Mavroudi I, Alpantaki K, Kouvidi E, Kontakis G, Papadaki HA (2017) Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton’s jelly and bone marrow-derived mesenchymal stem cells. Stem Cell Res Ther 8:102
Gazdic M, Volarevic V, Harrell CR, Fellabaum C, Jovicic N, Arsenijevic N, Stojkovic M (2018) Stem cells therapy for spinal cord injury. Int J Mol Sci 19:1039
Volarevic V, Nurkovic J, Arsenijevic N, Stojkovic M (2014) Concise review: therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis. Stem Cells 32:2818–2823
Harrell CR, Volarevic A, Djonov V, Volarevic V (2021) Mesenchymal stem cell-derived exosomes as new remedy for the treatment of neurocognitive disorders. Int J Mol Sci 22:1433
Harrell CR, Djonov V, Volarevic V (2021) The cross-talk between mesenchymal stem cells and immune cells in tissue repair and regeneration. Int J Mol Sci 22:2472
Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V (2019) Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome. Cells 8:467
Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N (2019) Biological functions of mesenchymal stem cells and clinical implications. Cell Mol Life Sci 76:3323–3348
Volarevic V, Markovic BS, Gazdic M, Volarevic A, Jovicic N, Arsenijevic N, Armstrong L, Djonov V, Lako M, Stojkovic M (2018) Ethical and safety issues of stem cell-based therapy. Int J Med Sci 15:36–45
Harrell CR, Volarevic V (2021) Apoptosis: a friend or foe in mesenchymal stem cell-based immunosuppression. Adv Protein Chem Struct Biol 126:39–62
Jakovljevic J, Harrell CR, Fellabaum C, Arsenijevic A, Jovicic N, Volarevic V (2018) Modulation of autophagy as new approach in mesenchymal stem cell-based therapy. Biomed Pharmacother 104:404–410
Qin C, Bai L, Li Y, Wang K (2022) The functional mechanism of bone marrow-derived mesenchymal stem cells in the treatment of animal models with Alzheimer’s disease: crosstalk between autophagy and apoptosis. Stem Cell Res Ther 13:90
Menshikov M, Zubkova E, Stafeev I, Parfyonova Y (2021) Autophagy, mesenchymal stem cell differentiation, and secretion. Biomedicines 9:1178
He J, Liu J, Huang Y, Tang X, Xiao H, Hu Z (2021) Oxidative stress, inflammation, and autophagy: potential targets of mesenchymal stem cells-based therapies in ischemic stroke. Front Neurosci 15:641157
Deng J, Zhong L, Zhou Z, Gu C, Huang X, Shen L, Cao S, Ren Z, Zuo Z, Deng J, Yu S (2021) Autophagy: a promising therapeutic target for improving mesenchymal stem cell biological functions. Mol Cell Biochem 476:1135–1149
Denton D, Xu T, Kumar S (2015) Autophagy as a pro-death pathway. Immunol Cell Biol 93:35–42
Kim KH, Lee MS (2014) Autophagy–a key player in cellular and body metabolism. Nat Rev Endocrinol 10:322–337
Feng Y, He D, Yao Z, Klionsky DJ (2014) The machinery of macroautophagy. Cell Res 24:24–41
Wong AS, Cheung ZH, Ip NY (2011) Molecular machinery of macroautophagy and its deregulation in diseases. Biochim Biophys Acta 1812:1490–1497
Li WW, Li J, Bao JK (2012) Microautophagy: lesser-known self-eating. Cell Mol Life Sci 69:1125–1136
Cuervo AM (2010) Chaperone-mediated autophagy: selectivity pays off. Trends Endocrinol Metab 21:142–150
Rubinsztein DC, Mariño G, Kroemer G (2011) Autophagy and aging. Cell 146:682–695
Nuschke A, Rodrigues M, Stolz DB, Chu CT, Griffith L, Wells A (2014) Human mesenchymal stem cells/multipotent stromal cells consume accumulated autophagosomes early in differentiation. Stem Cell Res Ther 5:140
Chang TC, Hsu MF, Wu KK (2015) High glucose induces bone marrow-derived mesenchymal stem cell senescence by upregulating autophagy. PLoS ONE 10:e0126537
Capasso S, Alessio N, Squillaro T, Di Bernardo G, Melone MA, Cipollaro M, Peluso G, Galderisi U (2015) Changes in autophagy, proteasome activity and metabolism to determine a specific signature for acute and chronic senescent mesenchymal stromal cells. Oncotarget 6:39457–39468
Molaei S, Roudkenar MH, Amiri F, Harati MD, Bahadori M, Jaleh F, Jalili MA, Mohammadi RA (2015) Down-regulation of the autophagy gene, ATG7, protects bone marrow-derived mesenchymal stem cells from stressful conditions. Blood Res 50:80–86
Sbrana FV, Cortini M, Avnet S, Perut F, Columbaro M, De Milito A, Baldini N (2016) The role of autophagy in the maintenance of stemness and differentiation of mesenchymal stem cells. Stem Cell Rev Rep. 12:621–633
Xiang X, Zhao J, Xu G, Li Y, Zhang W (2011) mTOR and the differentiation of mesenchymal stem cells. Acta Biochim Biophys Sin (Shanghai) 43:501–510
Dong W, Zhang P, Fu Y, Ge J, Cheng J, Yuan H, Jiang H (2015) Roles of SATB2 in site-specific stemness, autophagy and senescence of bone marrow mesenchymal stem cells. J Cell Physiol 230:680–690
Wang L, Fan J, Lin YS, Guo YS, Gao B, Shi QY, Wei BY, Chen L, Yang L, Liu J, Luo ZJ (2015) Glucocorticoids induce autophagy in rat bone marrow mesenchymal stem cells. Mol Med Rep 11:2711–2716
Whittier X, Saag KG (2016) Glucocorticoid-induced Osteoporosis. Rheum Dis Clin North Am 42:177–189
Park S, Choi Y, Jung N, Kim J, Oh S, Yu Y, Ahn JH, Jo I, Choi BO, Jung SC (2017) Autophagy induction in the skeletal myogenic differentiation of human tonsil-derived mesenchymal stem cells. Int J Mol Med 39:831–840
Russo FP, Parola M (2012) Stem cells in liver failure. Best Pract Res Clin Gastroenterol 26:35–45
Ugland H, Naderi S, Brech A, Collas P, Blomhoff HK (2011) cAMP induces autophagy via a novel pathway involving ERK, cyclin E and Beclin 1. Autophagy 7:1199–1211
Park M, Kim YH, Woo SY, Lee HJ, Yu Y, Kim HS, Park YS, Jo I, Park JW, Jung SC, Lee H, Jeong B, Ryu KH (2015) Tonsil-derived mesenchymal stem cells ameliorate CCl4-induced liver fibrosis in mice via autophagy activation. Sci Rep 5:8616
Sanchez CG, Penfornis P, Oskowitz AZ, Boonjindasup AG, Cai DZ, Dhule SS, Rowan BG, Kelekar A, Krause DS, Pochampally RR (2011) Activation of autophagy in mesenchymal stem cells provides tumor stromal support. Carcinogenesis 32:964–972
Hou J, Han ZP, Jing YY, Yang X, Zhang SS, Sun K, Hao C, Meng Y, Yu FH, Liu XQ, Shi YF, Wu MC, Zhang L, Wei LX (2013) Autophagy prevents irradiation injury and maintains stemness through decreasing ROS generation in mesenchymal stem cells. Cell Death Dis 4:e844
Liu GY, Jiang XX, Zhu X, He WY, Kuang YL, Ren K, Lin Y, Gou X (2015) ROS activates JNK-mediated autophagy to counteract apoptosis in mouse mesenchymal stem cells in vitro. Acta Pharmacol Sin 36:1473–1479
Luo S, Rubinsztein DC (2007) Atg5 and Bcl-2 provide novel insights into the interplay between apoptosis and autophagy. Cell Death Differ 14:1247–1250
Maiuri MC, Criollo A, Tasdemir E, Vicencio JM, Tajeddine N, Hickman JA, Geneste O, Kroemer G (2007) BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy 3:374–376
Levin-Salomon V, Bialik S, Kimchi A (2014) DAP-kinase and autophagy. Apoptosis 19:346–356
Miao C, Lei M, Hu W, Han S, Wang Q (2017) A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction. Stem Cell Res Ther 8:242
El Nashar EM, Alghamdi MA, Alasmari WA, Hussein MMA, Hamza E, Taha RI, Ahmed MM, Al-Khater KM, Abdelfattah-Hassan A (2021) Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-β1/Smad and PI3K/AKT signaling pathways. Cells 10:2475
Wu DJ, Adamopoulos IE (2017) Autophagy and autoimmunity. Clin Immunol 176:55–62
Terman A, Brunk UT (2005) Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res 68:355–365
Yin XM, Ding WX, Gao W (2008) Autophagy in the liver. Hepatology 47:1773–1785
Patel AS, Lin L, Geyer A, Haspel JA, An CH, Cao J, Rosas IO, Morse D (2012) Autophagy in idiopathic pulmonary fibrosis. PLoS ONE 7:1–9
Millecamps S, Julien JP (2013) Axonal transport deficits and neurodegenerative diseases. Nat Rev Neurosci 14:161–176
Shin JY, Park HJ, Kim HN, Oh SH, Bae JS, Ha HJ, Lee PH (2014) Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models. Autophagy 10:32–44
Gergely P Jr, Grossman C, Niland B, Puskas F, Neupane H, Allam F, Banki K, Phillips PE, Perl A (2002) Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum 46:175–190
Caza TN, Fernandez DR, Talaber G, Oaks Z, Haas M, Madaio MP, Lai ZW, Miklossy G, Singh RR, Chudakov DM, Malorni W, Middleton F, Banki K, Perl A (2014) HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE. Ann Rheum Dis 73:1888–1897
Martinez J, Cunha LD, Park S, Yang M, Lu Q, Orchard R, Li QZ, Yan M, Janke L, Guy C, Linkermann A, Virgin HW, Green DR (2016) Noncanonical autophagy inhibits the autoinflammatory, lupus-like response to dying cells. Nature 533:115–119
Goswami TK, Singh M, Dhawan M, Mitra S, Emran TB, Rabaan AA, Mutair AA, Alawi ZA, Alhumaid S, Dhama K (2022) Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders-advances and challenges. Hum Vaccin Immunother 18:2035117
Chen J, Wang Q, Feng X, Zhang Z, Geng L, Xu T, Wang D, Sun L (2016) Umbilical cord-derived mesenchymal stem cells suppress autophagy of T cells in patients with systemic lupus erythematosus via transfer of mitochondria. Stem Cells Int 2016:4062789
Zhao K, Hao H, Liu J, Tong C, Cheng Y, Xie Z, Zang L, Mu Y, Han W (2015) Bone marrow-derived mesenchymal stem cells ameliorate chronic high glucose-induced β-cell injury through modulation of autophagy. Cell Death Dis 17(6):e1885
Ye G, Wang P, Xie Z, Cao Q, Li J, Zheng G, Wang S, Li M, Liu W, Cen S, Li Z, Yu W, Wu Y, Shen H (2021) Autophagy-mediated activation of mucosal-associated invariant T cells driven by mesenchymal stem cell-derived IL-15. Stem Cell Rep 16:926–939
Gao L, Cen S, Wang P, Xie Z, Liu Z, Deng W, Su H, Wu X, Wang S, Li J, Ouyang Y, Wu Y, Shen H (2016) Autophagy improves the immunosuppression of CD4+T cells by mesenchymal stem cells through transforming growth Factor-β1. Stem Cells Transl Med 5:1496–1505
Volarevic V, Gazdic M, Simovic Markovic B, Jovicic N, Djonov V, Arsenijevic N (2017) Mesenchymal stem cell-derived factors: immuno-modulatory effects and therapeutic potential. BioFactors 43:633–644
Kim KW, Moon SJ, Park MJ, Kim BM, Kim EK, Lee SH, Lee EJ, Chung BH, Yang CW, Cho ML (2015) Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease. Stem Cell Res Ther 6:202
Dang S, Xu H, Xu C, Cai W, Li Q, Cheng Y, Jin M, Wang RX, Peng Y, Zhang Y, Wu C, He X, Wan B, Zhang Y (2014) Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis. Autophagy 10:1301–1315
Amiri F, Molaei S, Bahadori M, Nasiri F, Deyhim MR, Jalili MA, Nourani MR, Habibi RM (2016) Autophagy-modulated human bone marrow-derived mesenchymal stem cells accelerate liver restoration in mouse models of acute liver failure. Iran Biomed J 20:135–144
Joshi J, Kothapalli CR (2022) Role of inflammatory niche and adult cardiomyocyte coculture on differentiation, matrix synthesis, and secretome release by human bone marrow mesenchymal stem cells. Appl Biochem Biotechnol 194:1938–1954
Hare JM (2009) Translational development of mesenchymal stem cell therapy for cardiovascular diseases. Tex Heart Inst J 36:145–147
Wei W, An Y, An Y, Fei D, Wang Q (2018) Activation of autophagy in periodontal ligament mesenchymal stem cells promotes angiogenesis in periodontitis. J Periodontol 89:718–727
Liu J, Hao H, Huang H, Tong C, Ti D, Dong L, Chen D, Zhao Y, Liu H, Han W, Fu X (2015) Hypoxia regulates the therapeutic potential of mesenchymal stem cells through enhanced autophagy. Int J Low Extrem Wounds 14:63–72
Boyette LB, Creasey OA, Guzik L, Lozito T, Tuan RS (2014) Human bone marrow-derived mesenchymal stem cells display enhanced clonogenicity but impaired differentiation with hypoxic preconditioning. Stem Cells Transl Med 3:241–254
Xia Y, Ling X, Hu G, Zhu Q, Zhang J, Li Q, Zhao B, Wang Y, Deng Z (2020) Small extracellular vesicles secreted by human iPSC-derived MSC enhance angiogenesis through inhibiting STAT3-dependent autophagy in ischemic stroke. Stem Cell Res Ther 11:313
Acknowledgements
None.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Ethics declarations
Disclosure of Interests
All authors declare they have no conflict of interest.
Compliance with Ethical Standards
This article does not contain any studies with human participants and animals performed by any of the authors.
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Harrell, C.R., Pavlovic, D., Volarevic, V. (2023). Autophagy in Mesenchymal Stem Cell-Based Therapy. In: Shravage, B.V., Turksen, K. (eds) Autophagy in Stem Cell Maintenance and Differentiation. Stem Cell Biology and Regenerative Medicine, vol 73. Springer, Cham. https://doi.org/10.1007/978-3-031-17362-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-031-17362-2_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-17361-5
Online ISBN: 978-3-031-17362-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)